日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer.

去势抵抗性前列腺癌患者接受恩扎卢胺单药治疗或联合镭-223治疗期间的免疫调节

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17101730
Zang Peter D, Da Silva Diane M, Liu Zhang-Xu, Kandukuri Shivani, Tsao-Wei Denice, D'Souza Anishka, Kast W Martin, Pal Sumanta K, Kefauver Cheryl, Juanqueira Maribel, Yang Lixin, Quinn David I, Dorff Tanya B
免疫/内分泌
前列腺癌
发表日期：2025
文献求助 收藏

Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)

加州癌症联盟 II 期吉西他滨-艾立布林联合疗法治疗不适合顺铂治疗的转移性尿路上皮癌患者的试验：最终报告 (NCI-9653)

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.19.00861
Sadeghi, Sarmad; Groshen, Susan G; Tsao-Wei, Denice D; Parikh, Rahul; Mortazavi, Amir; Dorff, Tanya B; Kefauver, Cheryl; Hoimes, Christopher; Doyle, Laurence; Quinn, David I; Newman, Edward; Lara, Primo N Jr
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia

GTI-2040（一种核糖核苷酸还原酶反义寡核苷酸）联合高剂量阿糖胞苷治疗复发/难治性急性髓系白血病患者的I期研究

期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.3109/10428194.2013.838764
Klisovic, Rebecca B; Blum, William; Liu, Zhongfa; Xie, Zhiliang; Kefauver, Cheryl; Huynh, Lenguyen; Zwiebel, James A; Devine, Steven M; Byrd, John C; Grever, Michael R; Chan, Kenneth K; Marcucci, Guido
白血病
发表日期：2014
文献求助 收藏

A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemia

来那度胺治疗有症状复发性慢性淋巴细胞白血病的剂量递增可行性研究

期刊:Leukemia Research
影响因子:2.2
doi:10.1016/j.leukres.2014.05.011
Maddocks, Kami; Ruppert, Amy S; Browning, Rebekah; Jones, Jeffrey; Flynn, Joseph; Kefauver, Cheryl; Gao, Yue; Jiang, Yao; Rozewski, Darlene M; Poi, Ming; Phelps, Mitch A; Harper, Erica; Johnson, Amy J; Byrd, John C; Andritsos, Leslie A
细胞生物学
白血病
发表日期：2014
文献求助 收藏

Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia

17-烯丙基氨基-17-去甲氧基格尔德霉素联合硼替佐米治疗复发或难治性急性髓系白血病的药代动力学和剂量递增研究

期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.3109/10428194.2012.760733
Walker, Alison R; Klisovic, Rebecca; Johnston, Jeffrey S; Jiang, Yao; Geyer, Susan; Kefauver, Cheryl; Binkley, Philip; Byrd, John C; Grever, Michael R; Garzon, Ramiro; Phelps, Mitch A; Marcucci, Guido; Blum, Kristie A; Blum, William
白血病
发表日期：2013
文献求助 收藏

A dose escalation and pharmacodynamic study of triapine and radiation in patients with locally advanced pancreas cancer

一项关于三嗪类利尿剂联合放射治疗局部晚期胰腺癌患者的剂量递增和药效学研究

期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2012.06.003
Martin, Ludmila Katherine; Grecula, John; Jia, Guang; Wei, Lai; Yang, Xiangyu; Otterson, Gregory A; Wu, Xin; Harper, Erica; Kefauver, Cheryl; Zhou, Bing-Sen; Yen, Yun; Bloomston, Mark; Knopp, Michael; Ivy, S Percy; Grever, Michael; Bekaii-Saab, Tanios
胰腺癌
肿瘤
肿瘤免疫
发表日期：2012
文献求助 收藏

A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma

贝伐珠单抗联合高剂量干扰素α-2B治疗转移性黑色素瘤的II期临床试验

期刊:Journal of Immunotherapy
影响因子:2.9
doi:10.1097/CJI.0b013e31821dcefd
Grignol, Valerie P; Olencki, Thomas; Relekar, Kiran; Taylor, Cynthia; Kibler, Amanda; Kefauver, Cheryl; Wei, Lai; Walker, Michael J; Chen, Helen X; Kendra, Kari; Carson, William E 3rd
黑色素瘤
发表日期：2011
文献求助 收藏

Dose escalation of lenalidomide in relapsed or refractory acute leukemias

复发或难治性急性白血病来那度胺剂量递增

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2010.30.3339
Blum, William; Klisovic, Rebecca B; Becker, Heiko; Yang, Xiaoxia; Rozewski, Darlene M; Phelps, Mitch A; Garzon, Ramiro; Walker, Alison; Chandler, Jason C; Whitman, Susan P; Curfman, John; Liu, Shujun; Schaaf, Larry; Mickle, Jon; Kefauver, Cheryl; Devine, Steven M; Grever, Michael R; Marcucci, Guido; Byrd, John C
白血病
发表日期：2010
文献求助 收藏

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

地西他滨10天方案治疗老年AML患者的临床反应及miR-29b预测意义

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.1002650107
Blum, William; Garzon, Ramiro; Klisovic, Rebecca B; Schwind, Sebastian; Walker, Alison; Geyer, Susan; Liu, Shujun; Havelange, Violaine; Becker, Heiko; Schaaf, Larry; Mickle, Jon; Devine, Hollie; Kefauver, Cheryl; Devine, Steven M; Chan, Kenneth K; Heerema, Nyla A; Bloomfield, Clara D; Grever, Michael R; Byrd, John C; Villalona-Calero, Miguel; Croce, Carlo M; Marcucci, Guido
发表日期：2010
文献求助 收藏

Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias

一项针对复发或难治性急性白血病患者的新型黄酮吡啶醇给药方案的I期临床和药代动力学研究

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2009.017103
Blum, William; Phelps, Mitch A; Klisovic, Rebecca B; Rozewski, Darlene M; Ni, Wenjun; Albanese, Katie A; Rovin, Brad; Kefauver, Cheryl; Devine, Steven M; Lucas, David M; Johnson, Amy; Schaaf, Larry J; Byrd, John C; Marcucci, Guido; Grever, Michael R
白血病
发表日期：2010
文献求助 收藏